Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Spa Therapy for Upper or Lower Limb Lymphoedema
- Status
- RECRUITING
- Phase
- NA
ARQ761 + PARP Inhibitor in Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart
- Status
- COMPLETED
- Phase
- NA
Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma
- Status
- RECRUITING
- Phase
- NA
WB-EMS and Nutrition in Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
- Status
- UNKNOWN
- Phase
- PHASE2
Geriatric Communication Skills Training Program for Oncology Clinicians
- Status
- COMPLETED
- Phase
- NA
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
- Status
- COMPLETED
- Phase
- PHASE1
Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO
- Status
- COMPLETED
- Phase
- NA
Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL
- Status
- RECRUITING
- Phase
- N/A
Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)
- Status
- UNKNOWN
- Phase
- N/A
Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2